Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
Repository logo
  • Colleges, Institutes & Collections
  • Browse AAU-ETD
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Српски
  • Yкраї́нська
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Selamawit Walle"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Safety Profile of Azathioprine among Inflammatory Bowel Disease Patients in Addis Ababa University, College of Medicine And Health Science, School of Medicine, Department of Internal Medicine, Gastroenterology & Hepatology Unit, Addis Ababa. Ethiopia. Two Year Retrospective Study
    (Addis Ababa University, 2024-10-23) Selamawit Walle; Rezene Berhe
    Azathioprine, is the pro drug of 6-mercaptopurine which is a purine analogue. It inhibits cell growth by directly interfering with nucleic acid synthesis. It has long been a cornerstone in the management of inflammatory bowel disease (IBD), encompassing both Crohn's disease and ulcerative colitis. As with any potent medication, understanding its safety profile is paramount in optimizing patient care.

Home |Privacy policy |End User Agreement |Send Feedback |Library Website

Addis Ababa University © 2023